Sitrin Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.73M | Sell |
19,120
-41
| -0.2% | -$14.6K | 3.37% | 10 |
|
|
2025
Q4 | $6.27M | Sell |
19,161
-31
| -0.2% | -$9.83K | 2.98% | 18 |
|
|
2025
Q3 | $5.42M | Sell |
19,192
-730
| -4% | -$212K | 2.6% | 23 |
|
|
2025
Q2 | $5.56M | Sell |
19,922
-2,678
| -12% | -$759K | 2.84% | 20 |
|
|
2025
Q1 | $7.04M | Buy |
22,600
+14
| +0.1% | +$4.13K | 3.8% | 9 |
|
|
2024
Q4 | $5.89M | Buy |
22,586
+36
| +0.2% | +$10.7K | 2.97% | 15 |
|
|
2024
Q3 | $7.27M | Sell |
22,550
-88
| -0.4% | -$28.8K | 3.63% | 9 |
|
|
2024
Q2 | $7.07M | Buy |
22,638
+65
| +0.3% | +$19.1K | 3.76% | 9 |
|
|
2024
Q1 | $6.42M | Sell |
22,573
-234
| -1% | -$68.5K | 3.51% | 13 |
|
|
2023
Q4 | $6.57M | Sell |
22,807
-319
| -1% | -$86.9K | 3.83% | 4 |
|
|
2023
Q3 | $6.22M | Sell |
23,126
-2,651
| -10% | -$662K | 3.88% | 4 |
|
|
2023
Q2 | $5.72M | Buy |
25,777
+287
| +1% | +$66.6K | 3.22% | 18 |
|
|
2023
Q1 | $6.16M | Sell |
25,490
-186
| -0.7% | -$45.7K | 3.73% | 6 |
|
|
2022
Q4 | $6.74M | Sell |
25,676
-1,191
| -4% | -$319K | 4.3% | 6 |
|
|
2022
Q3 | $6.06M | Buy |
26,867
+331
| +1% | +$80.2K | 3.99% | 4 |
|
|
2022
Q2 | $6.46M | Sell |
26,536
-531
| -2% | -$130K | 4.12% | 3 |
|
|
2022
Q1 | $6.54M | Buy |
27,067
+79
| +0.3% | +$18.2K | 3.28% | 9 |
|
|
2021
Q4 | $6.07M | Buy |
26,988
+93
| +0.3% | +$19.6K | 2.86% | 23 |
|
|
2021
Q3 | $5.72M | Buy |
26,895
+17
| +0.1% | +$3.91K | 2.74% | 28 |
|
|
2021
Q2 | $6.55M | Sell |
26,878
-1,467
| -5% | -$361K | 2.95% | 21 |
|
|
2021
Q1 | $7.05M | Sell |
28,345
-152
| -0.5% | -$36.3K | 3.35% | 6 |
|
|
2020
Q4 | $6.55M | Buy |
28,497
+126
| +0.4% | +$29.1K | 3.27% | 9 |
|
|
2020
Q3 | $6.96M | Buy |
28,371
+148
| +0.5% | +$36.7K | 3.69% | 5 |
|
|
2020
Q2 | $6.66M | Sell |
28,223
-1,831
| -6% | -$418K | 3.97% | 10 |
|
|
2020
Q1 | $6.09M | Sell |
30,054
-2,062
| -6% | -$450K | 3.61% | 12 |
|
|
2019
Q4 | $7.74M | Sell |
32,116
-109
| -0.3% | -$24K | 3.96% | 7 |
|
|
2019
Q3 | $6.24M | Sell |
32,225
-163
| -0.5% | -$31.3K | 3.4% | 18 |
|
|
2019
Q2 | $5.97M | Sell |
32,388
-310
| -0.9% | -$55.5K | 3.18% | 21 |
|
|
2019
Q1 | $6.21M | Buy |
32,698
+268
| +0.8% | +$51.2K | 3.33% | 14 |
|
|
2018
Q4 | $6.31M | Buy |
32,430
+337
| +1% | +$65.7K | 3.85% | 7 |
|
|
2018
Q3 | $6.65M | Buy |
32,093
+668
| +2% | +$132K | 3.58% | 10 |
|
|
2018
Q2 | $5.8M | Buy |
31,425
+1,863
| +6% | +$330K | 3.29% | 14 |
|
|
2018
Q1 | $5.04M | Buy |
29,562
+83
| +0.3% | +$15.2K | 3.25% | 16 |
|
|
2017
Q4 | $5.13M | Sell |
29,479
-415
| -1% | -$73.4K | 3.24% | 14 |
|
|
2017
Q3 | $5.57M | Sell |
29,894
-322
| -1% | -$57.1K | 3.59% | 11 |
|
|
2017
Q2 | $5.2M | Buy |
30,216
+557
| +2% | +$90.6K | 3.53% | 12 |
|
|
2017
Q1 | $4.87M | Sell |
29,659
-184
| -0.6% | -$30.6K | 3.5% | 12 |
|
|
2016
Q4 | $4.36M | Buy |
29,843
+333
| +1% | +$50.1K | 3.38% | 16 |
|
|
2016
Q3 | $4.92M | Buy |
29,510
+1
| +0% | +$169 | 3.87% | 8 |
|
|
2016
Q2 | $4.49M | Buy |
29,509
+1,392
| +5% | +$216K | 3.61% | 10 |
|
|
2016
Q1 | $4.22M | Sell |
28,117
-1,127
| -4% | -$167K | 3.35% | 10 |
|
|
2015
Q4 | $4.45M | Buy |
+29,244
| New | +$4.6M | 3.9% | 6 |
|
Other funds holding AMGN
VCM
VPM
Sitrin Capital Management's AMGN Position: Q1 2026 in Review
Sitrin Capital Management reduced its Amgen (AMGN) stake by 0.21% in Q1 2026, selling an estimated $14.6K and leaving 19,120 shares worth $6.73M. The position accounts for 3.37% of the portfolio, ranked #10.
Sitrin Capital Management first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. The position peaked at $7.74M in Q4 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Sitrin Capital Management held 19,120 shares of Amgen worth $6.73M as of Q1 2026.
- Sitrin Capital Management sold 41 Amgen shares in Q1 2026, an estimated $14.6K.
- Amgen made up 3.37% of Sitrin Capital Management's portfolio in Q1 2026, its #10 holding.
- Sitrin Capital Management first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- Sitrin Capital Management's Amgen position peaked at $7.74M in Q4 2019.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Sitrin Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.